Dioxychlor is an agent that destroys fungi, bacteria and viruses by the action of atomic oxygen. In numerous trials, this product has been further developed and optimized both in its manufacturing form and in its effect in close collaboration between researchers at the Bradford Research Institute and Stanford University, the National Cancer Institute (NCI) and the Mayo Clinics. The effectiveness of this oxygen preparation has been proven with over 50,000 infusions for various indications worldwide. The active ingredient in dioxychlor is, as the name suggests, chlorine dioxide.

Quote from the Seegarten Clinic Switzerland:

Influenza, Herpes I and II, Hepatitis-B, Epstein-Barr, Cytomegalovirus, Polio, Toxoplasmosis and Tuberculosis. Dioxychlor has also been successfully used for virulent mycoses such as Candida albicans and Mycoplasma, for blood parasites, as well as for pleomorphic bacteria, which are mostly found in multiple allergies. Other areas of application include follow-up therapy after long-term use of antibiotics and their sequelae, such as chronic fatigue syndrome (CFS, Epstein-Barr, HHV-6 virus). The convincing successes of dioxychlor therapy in Europe and the USA have expanded the list of indications to include other disease states in addition to those already mentioned: gingivitis, weakness of the immune system, cystic fibrosis, recurrent pneumonia and broncho-pneumonia with recurrent infections..